¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) »ùÇà Á¶Á¦ ½ÃÀå
Next Generation Sequencing (NGS) Sample Preparation
»óǰÄÚµå : 1659425
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 88 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄý¼­(NGS) »ùÇà Á¶Á¦ ½ÃÀåÀº 2030³â±îÁö 105¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 39¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄý¼­(NGS) »ùÇà Á¶Á¦ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 18.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 105¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ½Ã¾à¡¤¼Ò¸ðǰÀº CAGR 19.7%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 69¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿öÅ©½ºÅ×ÀÌ¼Ç ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 15.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 11¾ï ´Þ·¯, Áß±¹Àº CAGR 17.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ Â÷¼¼´ë ½ÃÄý¼­(NGS) »ùÇà Á¶Á¦ ½ÃÀåÀº 2024³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 16¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 17.0%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 16.0%¿Í 15.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 13.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄý¼­(NGS) »ùÇà Á¶Á¦ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Â÷¼¼´ë ½ÃÄö½Ì(NGS) »ùÇà Á¶Á¦´Â À¯ÀüüÇÐÀ» ¾î¶»°Ô ¹ßÀü½Ãų °ÍÀΰ¡?

Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) »ùÇà Á¶Á¦´Â ¿¬±¸, ÀÓ»ó Áø´Ü ¹× ¸ÂÃã ÀǷḦ À§ÇÑ DNA ¹× RNAÀÇ Á¤È®ÇÑ ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÏ´Â À¯Àüü ½ÃÄö½Ì ÇÁ·Î¼¼½ºÀÇ Áß¿äÇÑ ´Ü°èÀÔ´Ï´Ù. ÀÌ °úÁ¤¿¡´Â DNA/RNA ÃßÃâ, ¶óÀ̺귯¸® Áغñ, Ç¥Àû ³óÃàÀÌ Æ÷ÇԵǸç, ÀÌ ¸ðµç °úÁ¤Àº °íǰÁú ½ÃÄö½Ì °á°ú¸¦ ¾ò±â À§ÇØ ÇʼöÀûÀ̸ç, NGS »ùÇà Á¶Á¦´Â ÀÚµ¿È­, ¸ÖƼÇ÷º½Ì, ´ÜÀÏ ¼¼Æ÷ ºÐ¼®°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î Å©°Ô ¹ßÀüÇÏ¿© º¸´Ù ºü¸£°í Á¤È®ÇÑ À¯Àüü ºÐ¼®ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. À¯ÀüüÇÐÀÌ Áúº´, ÀǾàǰ °³¹ß ¹× Áý´Ü À¯ÀüÇп¡ ´ëÇÑ ÀÌÇØ¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® ÀâÀ¸¸é¼­ È¿À²ÀûÀÎ ½Ã·á Áغñ´Â NGS ±â¼úÀÇ ÀáÀç·ÂÀ» ÃÖ´ëÇÑ È°¿ëÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù.

NGS »ùÇà Á¶Á¦ ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

ÁÖ¿ä Á¦Ç°À¸·Î´Â ½Ã¾à, ŰƮ, Àåºñ, ¼Ò¸ðǰÀÌ ÀÖÀ¸¸ç, ½Ã¾à ¹× ŰƮ´Â ¶óÀ̺귯¸® Áغñ¿Í Ç¥Àû ³óÃà¿¡ ÀÚÁÖ »ç¿ëµÇ¹Ç·Î ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¿öÅ©Ç÷ο쿡´Â DNA ÃßÃâ, ¶óÀ̺귯¸® Áغñ, ¶óÀ̺귯¸® Áغñ, Ç¥Àû ³óÃàÀÌ ÀÖÀ¸¸ç, ¶óÀ̺귯¸® Áغñ°¡ °¡Àå Å« ºÎ¹®ÀÔ´Ï´Ù. ÁÖ¿ä ÃÖÁ¾»ç¿ëÀڷδ Çмú¿¬±¸±â°ü, º´¿ø, Á¦¾àȸ»ç, ÀÓ»ó ½ÇÇè½Ç µîÀÌ ÀÖÀ¸¸ç, À̵éÀº ¸ðµÎ À¯Àüü ¿¬±¸ ¼öÇà, ¸ÂÃã Ä¡·á¹ý °³¹ß, À¯ÀüÀÚ Áúȯ Áø´ÜÀ» À§ÇØ NGS »ùÇà Àü󸮸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù.

NGS »ùÇà Á¶Á¦´Â °¢ ºÐ¾ß¿¡¼­ ¾î¶»°Ô äÅõǰí Àִ°¡?

Çмú¿¬±¸±â°üÀº NGS ½Ã·á ÁغñÀÇ °¡Àå Å« »ç¿ëÀÚÀ̸ç, À¯Àüü ¿¬±¸, À¯ÀüÀÚ ¹ßÇö ¿¬±¸, ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö¿¡ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. º´¿ø°ú ÀÓ»ó°Ë»ç½ÇÀº NGS ½Ã·á Àü󸮸¦ ÅëÇØ À¯ÀüÁúȯ Áø´Ü, °¨¿°¼º Áúȯ °ËÃâ, °³Àκ° ¸ÂÃã Ä¡·á °èȹ ¼ö¸³¿¡ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç´Â À¯ÀüÀÚ Ç¥Àû ¹ß±¼, ½Å¾à °³¹ß, ÀÓ»ó½ÃÇè¿¡ Ȱ¿ëÇϰí ÀÖÀ¸¸ç, À¯Àüü µ¥ÀÌÅÍ´Â ¾àÈ¿ ºÐ¼®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Áý´Ü À¯ÀüÇÐ ¹× Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ À¯ÀüÀÚ ºÐ¼®À» À§ÇØ ´ë±Ô¸ð ¿°±â¼­¿­ ºÐ¼®ÀÌ ÇÊ¿äÇÑ Á¤ºÎ Áö¿ø À¯Àüü ÇÁ·ÎÁ§Æ®¿Í ¹ÙÀÌ¿À¹ðÅ©¿¡¼­ NGS ½Ã·á Á¶Á¦°¡ ´õ¿í Ȱ¹ßÇÏ°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

NGS ½Ã·á Áغñ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

Â÷¼¼´ë ½ÃÄö½Ì »ùÇà Á¶Á¦ ½ÃÀåÀÇ ¼ºÀåÀº Áúº´ ¿¬±¸, ¸ÂÃãÇü ÀÇ·á, ÀǾàǰ °³¹ß¿¡¼­ À¯ÀüüÇп¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿È­ ¹× ´ÙÁßÈ­ ±â¼úÀÇ ¹ßÀüÀ¸·Î ½Ã·á ÁغñÀÇ È¿À²¼º°ú Á¤È®¼ºÀÌ Çâ»óµÇ¾î Àüü NGS ¿öÅ©Ç÷οìÀÇ ¼Óµµ°¡ »¡¶óÁ³½À´Ï´Ù. À¯ÀüÀû ÀλçÀÌÆ®¿¡ Å©°Ô ÀÇÁ¸ÇÏ´Â Á¤¹ÐÀÇ·áÀÇ ºÎ»óÀ¸·Î ÷´Ü ½Ã·á Áغñ ±â¼úÀÇ Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. À¯Àüü ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ±¸»ó°ú ÀÚ±Ý Áö¿øÀº ÀÓ»ó À¯ÀüüÇÐÀÇ È®´ë¿Í ÇÔ²² ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¾Ï Áø´Ü, Èñ±ÍÁúȯ Áø´Ü, °¨¿°¼º Áúȯ ¸ð´ÏÅ͸µ¿¡ NGSÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿À²ÀûÀÎ ½Ã·á Áغñ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(½Ã¾à¡¤¼Ò¸ðǰ, ¿öÅ©½ºÅ×À̼Ç), ¿öÅ©Ç÷οì(¹ÝÀÚµ¿ ¶óÀ̺귯¸® Á¶Á¦, NGS ¶óÀ̺귯¸® Á¶Á¦ ŰƮ, ÀÚµ¿ ¶óÀ̺귯¸® Á¶Á¦, Ŭ·Ð ÁõÆø), ¿ëµµ(Á¾¾çÇÐ, ¼ÒºñÀÚ À¯ÀüüÇÐ, ±ºÀ¯ÀüüÇÐ, ¿ªÇС¤¿¬±¸°³¹ß, ³ó¾÷À¯ÀüüÇС¤°úÇÐ ¼ö»ç, HLA ŸÀÌÇΡ¤¸é¿ª°è ¸ð´ÏÅ͸µ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(Çмú¿¬±¸, ÀÓ»ó ¿¬±¸, º´¿ø¡¤Áø·á¼Ò, Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ ÇÕ°è 32»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach US$10.5 Billion by 2030

The global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$3.9 Billion in the year 2024, is expected to reach US$10.5 Billion by 2030, growing at a CAGR of 18.2% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.7% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in the Workstations segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 17.0% CAGR

The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 17.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Next Generation Sequencing (NGS) Sample Preparation Market - Key Trends and Drivers Summarized

How Is Next Generation Sequencing (NGS) Sample Preparation Evolving Genomics?

Next Generation Sequencing (NGS) Sample Preparation is a crucial step in the genomic sequencing process, enabling the accurate analysis of DNA and RNA for research, clinical diagnostics, and personalized medicine. This process involves DNA/RNA extraction, library preparation, and target enrichment, all of which are critical for obtaining high-quality sequencing results. NGS sample preparation has advanced significantly with innovations such as automation, multiplexing, and single-cell analysis, allowing for faster and more precise genomic analysis. As genomics becomes integral to understanding diseases, drug development, and population genetics, efficient sample preparation is essential for unlocking the full potential of NGS technologies.

What Are the Key Segments in the NGS Sample Preparation Market?

Key products include reagents, kits, instruments, and consumables, with reagents and kits dominating the market due to their frequent use in library preparation and target enrichment. In terms of workflow, the market covers DNA extraction, library preparation, and target enrichment, with library preparation being the largest segment. Major end-users include academic research institutions, hospitals, pharmaceutical companies, and clinical laboratories, all of which use NGS sample preparation to conduct genomic studies, develop personalized therapies, and diagnose genetic disorders.

How Is NGS Sample Preparation Being Adopted Across Sectors?

Academic research institutions are the largest users of NGS sample preparation, utilizing it for genomic research, gene expression studies, and biomarker discovery. Hospitals and clinical laboratories leverage NGS sample preparation for diagnosing genetic disorders, detecting infectious diseases, and guiding personalized treatment plans. Pharmaceutical companies use it to identify genetic targets, develop new drugs, and conduct clinical trials, where genomic data plays a critical role in drug efficacy analysis. The growing interest in population genetics and precision medicine is further driving the adoption of NGS sample preparation in government-funded genomic projects and biobanks, which require large-scale sequencing for genetic analysis.

What Factors Are Driving the Growth in the NGS Sample Preparation Market?

The growth in the Next Generation Sequencing Sample Preparation market is driven by several factors, including the increasing demand for genomics in disease research, personalized medicine, and drug development. Technological advancements in automation and multiplexing have improved the efficiency and accuracy of sample preparation, enhancing the overall speed of NGS workflows. The rise of precision medicine, which relies heavily on genetic insights, has further fueled the need for advanced sample preparation techniques. Government initiatives and funding for genomic research, coupled with the expansion of clinical genomics, are contributing to market growth. The increasing use of NGS in cancer diagnostics, rare disease detection, and infectious disease monitoring is also driving the demand for efficient sample preparation solutions.

SCOPE OF STUDY:

The report analyzes the Next Generation Sequencing (NGS) Sample Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Consumables, Workstations); Workflow (Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation, Clonal Amplification); Application (Oncology, Consumer Genomics, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications); End-Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â